Integral Diagnostics Limited (ASX: IDX)
Health Care · Health Care Providers & Services · AU
AU$2.15
+0.94% today · -20.7% 1Y
Integral Diagnostics Limited (ASX: IDX) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $558.86M and employs 3,049 people.
Over the last twelve months the share price has lost 20.7%, trading between 1.91 and 2.76.
Tweenvest scores Integral Diagnostics Limited across four factors: quality 65/100, value 81/100, growth 79/100, dividend 79/100. Its strongest factor is value.
IDX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $558.86M
- Revenue (TTM)
- $545.57M
- P/E
- 37.07
- EPS
- 0.06
- Dividend yield
- 4.37%
- Beta (5Y)
- 0.18
- 52-week high
- AU$2.76
- 52-week low
- AU$1.91
- Avg volume (3M)
- —
- Shares outstanding
- 372.49M
- Employees
- 3,049
- Next earnings
- —
About Integral Diagnostics Limited
Integral Diagnostics Limited operates within the healthcare sector, providing essential diagnostic imaging services. These services are delivered to general practitioners, medical specialists, allied health professionals, and their patients across Australia and New Zealand. The company manages its service delivery through a network of 67 radiology clinics. Integral Diagnostics was incorporated in 2008 and maintains its primary corporate office in Melbourne, Australia.
- ISIN
- AU000000IDX2
- Founded
- 1967
- Listed since
- Oct 20, 2015
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Fulgent Genetics, Inc.NasdaqGM: FLGT | $598.18M | $21.40 | -1.56% |
| PT Famon Awal Bros Sedaya TbkIDX: PRAY | $592.89M | Rp760.00 | +1.33% |
| Shenzhen Neptunus Bioengineering Co., Ltd.SZSE: 000078 | $573.51M | CN¥1.46 | -2.01% |
| Chabiotech Co.,Ltd.KOSDAQ: A085660 | $564.22M | ₩8,200.00 | -3.07% |
| SBC Medical Group Holdings IncorporatedNasdaqGM: SBC | $557.43M | $5.33 | -1.66% |
| Cachet Pharmaceutical Co., Ltd.SZSE: 002462 | $539.16M | CN¥12.38 | +0.98% |
| Garofalo Health Care S.p.A.BIT: GHC | $534.65M | €5.40 | 0.00% |
| Vibhavadi Medical Center Public Company LimitedSET: VIBHA | $530.50M | ฿1.32 | -1.49% |
Figures last refreshed Oct 11, 2026.